489 related articles for article (PubMed ID: 31780025)
1. The effects of curcumin supplementation on glycemic status, lipid profile and hs-CRP levels in overweight/obese women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled clinical trial.
Sohaei S; Amani R; Tarrahi MJ; Ghasemi-Tehrani H
Complement Ther Med; 2019 Dec; 47():102201. PubMed ID: 31780025
[TBL] [Abstract][Full Text] [Related]
2. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
[TBL] [Abstract][Full Text] [Related]
3. Effects of Curcumin on Glycemic Control and Lipid Profile in Polycystic Ovary Syndrome: Systematic Review with Meta-Analysis and Trial Sequential Analysis.
Chien YJ; Chang CY; Wu MY; Chen CH; Horng YS; Wu HC
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669954
[TBL] [Abstract][Full Text] [Related]
4. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
5. Effects of curcumin on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
Jamilian M; Foroozanfard F; Kavossian E; Aghadavod E; Shafabakhsh R; Hoseini A; Asemi Z
Clin Nutr ESPEN; 2020 Apr; 36():128-133. PubMed ID: 32220355
[TBL] [Abstract][Full Text] [Related]
6. Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
Jamilian M; Razavi M; Fakhrie Kashan Z; Ghandi Y; Bagherian T; Asemi Z
Clin Endocrinol (Oxf); 2015 Jun; 82(6):885-91. PubMed ID: 25510442
[TBL] [Abstract][Full Text] [Related]
7. Effects of synbiotic supplementation on metabolic parameters and apelin in women with polycystic ovary syndrome: a randomised double-blind placebo-controlled trial.
Karimi E; Moini A; Yaseri M; Shirzad N; Sepidarkish M; Hossein-Boroujerdi M; Hosseinzadeh-Attar MJ
Br J Nutr; 2018 Feb; 119(4):398-406. PubMed ID: 29498342
[TBL] [Abstract][Full Text] [Related]
8. Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
Shabani A; Foroozanfard F; Kavossian E; Aghadavod E; Ostadmohammadi V; Reiter RJ; Eftekhar T; Asemi Z
J Affect Disord; 2019 May; 250():51-56. PubMed ID: 30831541
[TBL] [Abstract][Full Text] [Related]
9. Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial.
Samimi M; Jamilian M; Asemi Z; Esmaillzadeh A
Clin Nutr; 2015 Jun; 34(3):388-93. PubMed ID: 24973862
[TBL] [Abstract][Full Text] [Related]
10. Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
Foroozanfard F; Jamilian M; Jafari Z; Khassaf A; Hosseini A; Khorammian H; Asemi Z
Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):215-20. PubMed ID: 25868059
[TBL] [Abstract][Full Text] [Related]
11. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.
Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ
Nutr Metab (Lond); 2019; 16():8. PubMed ID: 30705687
[TBL] [Abstract][Full Text] [Related]
12. The effect of curcumin and high-content eicosapentaenoic acid supplementations in type 2 diabetes mellitus patients: a double-blinded randomized clinical trial.
Asghari KM; Saleh P; Salekzamani Y; Dolatkhah N; Aghamohammadzadeh N; Hashemian M
Nutr Diabetes; 2024 Apr; 14(1):14. PubMed ID: 38589346
[TBL] [Abstract][Full Text] [Related]
13. The effects of flaxseed supplementation on metabolic status in women with polycystic ovary syndrome: a randomized open-labeled controlled clinical trial.
Haidari F; Banaei-Jahromi N; Zakerkish M; Ahmadi K
Nutr J; 2020 Jan; 19(1):8. PubMed ID: 31980022
[TBL] [Abstract][Full Text] [Related]
14. The effect of L-carnitine supplementation on insulin resistance, sex hormone-binding globulin and lipid profile in overweight/obese women with polycystic ovary syndrome: a randomized clinical trial.
Sangouni AA; Pakravanfar F; Ghadiri-Anari A; Nadjarzadeh A; Fallahzadeh H; Hosseinzadeh M
Eur J Nutr; 2022 Apr; 61(3):1199-1207. PubMed ID: 34727201
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Effect of Curcumin in Women with Polycystic Ovary Syndrome Receiving Metformin: A Randomized Controlled Trial.
Sohrevardi SM; Heydari B; Azarpazhooh MR; Teymourzadeh M; Simental-Mendía LE; Atkin SL; Sahebkar A; Karimi-Zarchi M
Adv Exp Med Biol; 2021; 1308():109-117. PubMed ID: 33861440
[TBL] [Abstract][Full Text] [Related]
16. Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome.
Mohammadi E; Rafraf M; Farzadi L; Asghari-Jafarabadi M; Sabour S
Asia Pac J Clin Nutr; 2012; 21(4):511-8. PubMed ID: 23017309
[TBL] [Abstract][Full Text] [Related]
17. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.
Javed Z; Papageorgiou M; Deshmukh H; Kilpatrick ES; Mann V; Corless L; Abouda G; Rigby AS; Atkin SL; Sathyapalan T
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30658483
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study.
Mehrabani HH; Salehpour S; Amiri Z; Farahani SJ; Meyer BJ; Tahbaz F
J Am Coll Nutr; 2012 Apr; 31(2):117-25. PubMed ID: 22855917
[TBL] [Abstract][Full Text] [Related]
19. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Mirmasoumi G; Fazilati M; Foroozanfard F; Vahedpoor Z; Mahmoodi S; Taghizadeh M; Esfeh NK; Mohseni M; Karbassizadeh H; Asemi Z
Exp Clin Endocrinol Diabetes; 2018 Apr; 126(4):222-228. PubMed ID: 29117618
[TBL] [Abstract][Full Text] [Related]
20. The effects of nano-curcumin supplementation on glycemic control, blood pressure, lipid profile, and insulin resistance in patients with the metabolic syndrome: A randomized, double-blind clinical trial.
Bateni Z; Rahimi HR; Hedayati M; Afsharian S; Goudarzi R; Sohrab G
Phytother Res; 2021 Jul; 35(7):3945-3953. PubMed ID: 33851448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
